Mendelian randomization supports genetic liability to hospitalization for COVID-19 as a risk factor of pre-eclampsia
BackgroundPre-eclampsia and eclampsia are among the major threats to pregnant women and fetuses, but they can be mitigated by prevention and early screening. Existing observational research presents conflicting evidence regarding the causal effects of coronavirus disease 2019 (COVID-19) on pre-eclam...
Main Authors: | Weizhen Wu, Junning Zhang, Yizhuo Qiao, Yuehan Ren, Xuezhi Rao, Zhijie Xu, Baoxing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1327497/full |
Similar Items
-
Genetic liability between COVID-19 and pre-eclampsia/eclampsia: a Mendelian randomization study
by: Yuhang Xing, et al.
Published: (2023-12-01) -
Pre-eclampsia/Eclampsia
by: José Carlos Peraçoli, et al. -
A study of maternal morbidity and mortality DUE to Pre eclampsia and eclampsia
by: Vidya A. Thobbi, et al.
Published: (2017-07-01) -
Trends in the incidence of pre-eclampsia and eclampsia in Taiwan between 1998 and 2010
by: Te-Fu Chan, et al.
Published: (2015-06-01) -
Postpartum depression among women with pre-eclampsia and eclampsia in Tanzania; a call for integrative intervention
by: Barke Mbarak, et al.
Published: (2019-07-01)